US Stock MarketDetailed Quotes

LIXT Lixte Biotechnology

Watchlist
  • 1.9100
  • -0.4700-19.75%
Close Dec 18 16:00 ET
  • 1.8900
  • -0.0200-1.05%
Pre 08:40 ET
4.30MMarket Cap-1.10P/E (TTM)

Lixte Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1.40%-957.6K
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
19.55%-944.39K
1.58%-1.18M
-22.83%-1.27M
-11.32%-4.61M
-5.37%-1.21M
Net income from continuing operations
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
6.18%-6.31M
19.61%-1.63M
Change In working capital
-107.74%-78.39K
-71.26%61.19K
143.82%79.17K
-86.71%20.56K
-30.40%26.08K
59.34%-37.74K
395.50%212.91K
-164.04%-180.69K
1,251.39%154.76K
-72.78%37.47K
-Change in prepaid assets
-60.40%21.05K
70.12%102.56K
-94.50%-69.81K
59.15%102.46K
-52.52%24.92K
74.78%53.14K
47.02%60.28K
39.70%-35.89K
158.36%64.38K
-31.87%52.49K
-Change in payables and accrued expense
54.96%-65.47K
-180.68%-115.28K
1,566.31%89.93K
-3,291.37%-73.98K
17.36%-65.38K
-122.56%-145.36K
4,340.55%142.9K
-104.27%-6.13K
-93.50%2.32K
-866.25%-79.12K
-Change in other working capital
-162.34%-33.96K
659.63%73.91K
142.58%59.05K
-109.00%-7.92K
3.81%66.54K
194.09%54.48K
108.37%9.73K
-169.98%-138.67K
43.90%88.06K
27.48%64.09K
Cash from discontinued investing activities
Operating cash flow
-1.40%-957.6K
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
19.55%-944.39K
1.58%-1.18M
-22.83%-1.27M
-11.32%-4.61M
-5.37%-1.21M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
0
0
0
-38.86%3.14M
0
3.14M
0
157.59%6.28K
31.92%5.14M
0
Net common stock issuance
----
----
----
-38.98%3.14M
--0
----
----
----
39.34%5.14M
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--6.32K
--0
--41
--0
--6.28K
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
-38.86%3.14M
--0
--3.14M
--0
157.59%6.28K
31.92%5.14M
--0
Net cash flow
Beginning cash position
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
10.98%5.35M
-22.19%5.11M
-62.34%2.91M
8.22%4.09M
10.98%5.35M
-4.84%4.82M
10.09%6.56M
Current changes in cash
-143.67%-957.6K
30.32%-819.04K
37.62%-789.23K
-317.11%-1.15M
25.35%-902.12K
286.78%2.19M
-129.70%-1.18M
-20.94%-1.27M
315.72%529.65K
-6.30%-1.21M
End cash Position
-67.92%1.64M
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
-21.48%4.2M
-22.19%5.11M
-62.34%2.91M
8.22%4.09M
10.98%5.35M
10.98%5.35M
Free cash flow
-1.40%-957.6K
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
19.55%-944.39K
1.58%-1.18M
-22.83%-1.27M
-11.32%-4.61M
-5.37%-1.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1.40%-957.6K30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K19.55%-944.39K1.58%-1.18M-22.83%-1.27M-11.32%-4.61M-5.37%-1.21M
Net income from continuing operations 3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M6.18%-6.31M19.61%-1.63M
Change In working capital -107.74%-78.39K-71.26%61.19K143.82%79.17K-86.71%20.56K-30.40%26.08K59.34%-37.74K395.50%212.91K-164.04%-180.69K1,251.39%154.76K-72.78%37.47K
-Change in prepaid assets -60.40%21.05K70.12%102.56K-94.50%-69.81K59.15%102.46K-52.52%24.92K74.78%53.14K47.02%60.28K39.70%-35.89K158.36%64.38K-31.87%52.49K
-Change in payables and accrued expense 54.96%-65.47K-180.68%-115.28K1,566.31%89.93K-3,291.37%-73.98K17.36%-65.38K-122.56%-145.36K4,340.55%142.9K-104.27%-6.13K-93.50%2.32K-866.25%-79.12K
-Change in other working capital -162.34%-33.96K659.63%73.91K142.58%59.05K-109.00%-7.92K3.81%66.54K194.09%54.48K108.37%9.73K-169.98%-138.67K43.90%88.06K27.48%64.09K
Cash from discontinued investing activities
Operating cash flow -1.40%-957.6K30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K19.55%-944.39K1.58%-1.18M-22.83%-1.27M-11.32%-4.61M-5.37%-1.21M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 000-38.86%3.14M03.14M0157.59%6.28K31.92%5.14M0
Net common stock issuance -------------38.98%3.14M--0------------39.34%5.14M--0
Proceeds from stock option exercised by employees --0--0--0--6.32K--0--41--0--6.28K--0--0
Cash from discontinued financing activities
Financing cash flow --0--0--0-38.86%3.14M--0--3.14M--0157.59%6.28K31.92%5.14M--0
Net cash flow
Beginning cash position -10.91%2.6M-16.49%3.41M-21.48%4.2M10.98%5.35M-22.19%5.11M-62.34%2.91M8.22%4.09M10.98%5.35M-4.84%4.82M10.09%6.56M
Current changes in cash -143.67%-957.6K30.32%-819.04K37.62%-789.23K-317.11%-1.15M25.35%-902.12K286.78%2.19M-129.70%-1.18M-20.94%-1.27M315.72%529.65K-6.30%-1.21M
End cash Position -67.92%1.64M-10.91%2.6M-16.49%3.41M-21.48%4.2M-21.48%4.2M-22.19%5.11M-62.34%2.91M8.22%4.09M10.98%5.35M10.98%5.35M
Free cash flow -1.40%-957.6K30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K19.55%-944.39K1.58%-1.18M-22.83%-1.27M-11.32%-4.61M-5.37%-1.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data